...
search icon
vivs-img

VivoSim Labs, Inc., Common Stock

VIVS

NAQ

$2.01

+$0.02

(1.01%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.17M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
101.88K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.41 L
$21.96 H
$2.01

About VivoSim Labs, Inc., Common Stock

VivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameVIVSSectorS&P500
1-Week Return-12.39%-1.35%0.18%
1-Month Return39.46%-0.27%2.8%
3-Month Return5.13%-4.3%14.55%
6-Month Return-51.04%-8.76%4.96%
1-Year Return-69.76%-10.49%17.23%
3-Year Return-94.13%2.29%54.62%
5-Year Return-98.73%26.65%96.2%
10-Year Return-99.75%76.53%202.11%

Financials

Mar '21Mar '22Mar '23Mar '24Mar '255YR TREND
Total Revenue-1.50M370.00K109.00K144.00K[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":24.67,"profit":true},{"date":"2024-03-31","value":7.27,"profit":true},{"date":"2025-03-31","value":9.6,"profit":true}]
Cost of Revenue----5.00K[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Gross Profit-1.50M370.00K109.00K139.00K[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":24.67,"profit":true},{"date":"2024-03-31","value":7.27,"profit":true},{"date":"2025-03-31","value":9.27,"profit":true}]
Gross Margin-100.00%100.00%100.00%96.53%[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":96.53,"profit":true}]
Operating Expenses16.83M12.98M18.10M15.20M12.76M[{"date":"2021-03-31","value":92.96,"profit":true},{"date":"2022-03-31","value":71.7,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":83.95,"profit":true},{"date":"2025-03-31","value":70.47,"profit":true}]
Operating Income(16.83M)(11.48M)(17.73M)(15.09M)(12.62M)[{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1147900000,"profit":false},{"date":"2023-03-31","value":-1773100000,"profit":false},{"date":"2024-03-31","value":-1508600000,"profit":false},{"date":"2025-03-31","value":-1261600000,"profit":false}]
Total Non-Operating Income/Expense17.00K41.00K928.00K822.00K10.26M[{"date":"2021-03-31","value":0.17,"profit":true},{"date":"2022-03-31","value":0.4,"profit":true},{"date":"2023-03-31","value":9.04,"profit":true},{"date":"2024-03-31","value":8.01,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Pre-Tax Income(16.82M)(11.45M)(17.26M)(14.67M)(2.49M)[{"date":"2021-03-31","value":-1682400000,"profit":false},{"date":"2022-03-31","value":-1144600000,"profit":false},{"date":"2023-03-31","value":-1725700000,"profit":false},{"date":"2024-03-31","value":-1466900000,"profit":false},{"date":"2025-03-31","value":-248600000,"profit":false}]
Income Taxes2.00K2.00K2.00K2.00K2.00K[{"date":"2021-03-31","value":100,"profit":true},{"date":"2022-03-31","value":100,"profit":true},{"date":"2023-03-31","value":100,"profit":true},{"date":"2024-03-31","value":100,"profit":true},{"date":"2025-03-31","value":100,"profit":true}]
Income After Taxes(16.83M)(11.45M)(17.26M)(14.67M)(2.49M)[{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}]
Income From Continuous Operations(16.83M)(11.45M)(17.26M)(14.67M)(2.49M)[{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2021-03-31","value":"-","profit":true},{"date":"2022-03-31","value":"-","profit":true},{"date":"2023-03-31","value":"-","profit":true},{"date":"2024-03-31","value":"-","profit":true},{"date":"2025-03-31","value":"-","profit":true}]
Net Income(16.83M)(11.45M)(17.26M)(14.67M)(2.49M)[{"date":"2021-03-31","value":-1682600000,"profit":false},{"date":"2022-03-31","value":-1144800000,"profit":false},{"date":"2023-03-31","value":-1725900000,"profit":false},{"date":"2024-03-31","value":-1467100000,"profit":false},{"date":"2025-03-31","value":-248800000,"profit":false}]
EPS (Diluted)(29.43)(15.78)(23.77)(23.83)(3.11)[{"date":"2021-03-31","value":-2943.37,"profit":false},{"date":"2022-03-31","value":-1578.23,"profit":false},{"date":"2023-03-31","value":-2376.64,"profit":false},{"date":"2024-03-31","value":-2382.67,"profit":false},{"date":"2025-03-31","value":-311,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

VIVS
Cash Ratio 3.03
Current Ratio 3.25
Quick Ratio 3.25

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

VIVS
ROA (LTM) -75.10%
ROE (LTM) -35.31%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

VIVS
Debt Ratio Lower is generally better. Negative is bad. 0.28
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.72

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

VIVS
Trailing PE NM
Forward PE NM
P/S (TTM) 35.75
P/B 0.47
Price/FCF NM
EV/R 39.56
EV/Ebitda NM

FAQs

What is VivoSim Labs, Inc. share price today?

VivoSim Labs, Inc. (VIVS) share price today is $2.01

Can Indians buy VivoSim Labs, Inc. shares?

Yes, Indians can buy shares of VivoSim Labs, Inc. (VIVS) on Vested. To buy VivoSim Labs, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in VIVS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of VivoSim Labs, Inc. be purchased?

Yes, you can purchase fractional shares of VivoSim Labs, Inc. (VIVS) via the Vested app. You can start investing in VivoSim Labs, Inc. (VIVS) with a minimum investment of $1.

How to invest in VivoSim Labs, Inc. shares from India?

You can invest in shares of VivoSim Labs, Inc. (VIVS) via Vested in three simple steps:

  • Click on Sign Up or Invest in VIVS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in VivoSim Labs, Inc. shares
What is VivoSim Labs, Inc. 52-week high and low stock price?

The 52-week high price of VivoSim Labs, Inc. (VIVS) is $21.96. The 52-week low price of VivoSim Labs, Inc. (VIVS) is $1.41.

What is VivoSim Labs, Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of VivoSim Labs, Inc. (VIVS) is 0.47

What is the Market Cap of VivoSim Labs, Inc.?

The market capitalization of VivoSim Labs, Inc. (VIVS) is $5.17M

What is VivoSim Labs, Inc.’s stock symbol?

The stock symbol (or ticker) of VivoSim Labs, Inc. is VIVS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top